VC  Venrock

http://www.venrock.com





     Office Locations:

7 Bryant Park, 23rd Floor
New York, NY 10018
Phone: 212-444-4100
Fax: 212-444-4101

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Media & Digital Media

  •  

    Description:

    In 1969, Venrock was founded to continue Laurance Rockefeller's heritage of investment and building entrepreneur-backed companies, beginning with Intel. The firm has invested more than $2.5 billion in more than 440 companies, resulting in 125 IPO's over the past 40 years. Venrock investments span information technology, healthcare, media and energy sectors. The majority of Venrock investments are seed or first round, and range from investments of a couple hundred thousand to $10 million or more. Second round investments are considered where there is demonstrated progress toward market leadership. The firm currently has $3.0 billion under management, and offices in Palo Alto, New York City, and Cambridge. July of 2014, Venrock closed its seventh fund, bringing in $450 million in new capital. The firm will likely make about 8-10 new investments per year from this fund. Venrock raised $450 million for its eighth fund February of 2017.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Brian Ascher Partner
    Bryan Roberts Ph.D. Partner
    Camille Samuels Partner
    Mariana Mihalusova VP
    Mike Tyrrell Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/12/2023


      Scope3


      NY


      $20,000,000


      Series B


     

    Portfolio companies include:


      10X Genomics
        web link


      6Sense
        web link


      Ad Hoc Labs DBA Burner
        web link


      Aeglea Biotherapeutics
        web link


      Aledade
        web link


      Altruist
        web link


      Amino
        web link


      Amino Apps
        web link


      Amunix
        web link


      AppNexus


      Appthority
        web link


      Aria Diagnostics
        web link


      Aria Systems
        web link


      Astranis


      Astronomer
        web link


      Avalanche Biotechnologies
        web link


      AveXis


      Beckon
        web link


      BillFloat
        web link


      Boundless Learning
        web link


      Celladon
        web link


      Centricient
        web link


      CloudFlare
        web link


      Constellation Pharmaceuticals
        web link


      ConsultingMD
        web link


      CTERA Networks
        web link


      Cyteir Therapeutics
        web link


      Dataminr


      Dgraph
        web link


      Doctor on Demand
        web link


      Dollar Shave Club


      Dstillery


      Dynamic Signal
        web link


      Edge Therapeutics
        web link


      Evident.io
        web link


      Grand Rounds
        web link


      Inscripta
        web link


      Intarcia Therapeutics
        web link


      Interos


      Jiff
        web link


      Juno Therapeutics


      Kelonia Therapeutics
        web link


      Kyruus


      Luxe
        web link


      Lyra Health
        web link


      Make School
        web link


      Martini Media
        web link


      Metacrine
        web link


      Mevion Medical Systems
        web link


      Misty Robotics
        web link


      Muse Bio
        web link


      Niara
        web link


      Nightfall AI
        web link


      Numerated Growth Technologies
        web link


      Orchard Therapeutics


      Personal Capital
        web link


      Phononic


      PowerVision
        web link


      Q Factor Communications
        web link


      Quantenna Communications


      RedSeal


      RefleXion Medical
        web link


      REGENXBIO
        web link


      Salsify
        web link


      Scope3
        web link


      Shape Security
        web link


      Shockwave Medical
        web link


      Smartling
        web link


      SmithRx
        web link


      Spirox
        web link


      Stride Health
        web link


      Tricida


      Trumaker
        web link


      UNITY Biotechnology


      Vanilla
        web link


      VeloCloud
        web link


      VeloCloud Networks
        web link


      VelosBio
        web link


      Virta Health
        web link


      Waybridge
        web link


      Workframe
        web link


      YouNow
        web link


      Zafgen
        web link


      Zenefits
        web link


     

    Recent News: